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1. Introduction
Aflatoxins (AFs), secondary metabolites produced by Aspergillus Flavus and Aspergilluspara‐
siticus, are a numerous group of chemically related compounds characterised by high toxici‐
ty. Among these, aflatoxin B1 (AFB1) is the most potent known carcinogen for liver and,
together with aflatoxins B2 (AFB2), G1 (AFG1) and G2 (AFG2) is the most frequently found
and the most toxic of the group [1]. Therefore, maximum residue levels (MRLs) for AFB1
and for the sum of the four AFB1 + AFB2 + AFG1 + AFG2 (total aflatoxins) in food and feed
have been set by the European Union [2-4] and all over the world [5-7].
The occurrence of aflatoxins (AFs) has been widely reported in a variety of crops (including
maize, wheat, barley, rice, groundnuts, nuts, pistachios, cottonseed, and spices) which can
be infected pre-, during and post-harvest. Moreover, due to the relative stability of AFs to
thermal and chemical stresses, they are found on commodities despite the elimination of
mould, after long periods of storage, and also after the transformation of raw materials;
therefore the presence of AFs has also been ascertained in commodities such as composite
feed, flour, bakery products, and roasted peanuts.
In addition, products of the animal metabolism of aflatoxins could retain toxicity, such as in
the case of AFB1, which, once ingested, is rapidly absorbed and transformed into a hydroxy‐
lated metabolite. The latter is secreted into the milk and thus has been named aflatoxin M1
(AFM1). The hepatotoxicity and carcinogenic effects of AFM1 have also been demonstrated
and IARC have included this toxin in the group I human carcinogens as well as the parent
AFB1[1]. Milk and derived products can consequently also be implicated in the spreading of
aflatoxins. Therefore, most countries have also set up MRLs of AFM1 in milk, which varies
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from the 50 ng kg-1 established by the EU to the 500 ng kg-1 established by US FDA [2, 8]. More
restrictive MRLs have been decided by the EU for the presence of AFM1 in baby food [2].
A part from safety issue, food contamination caused by AFs also strongly affects economic
interests; so much effortis devoted to the development of analytical methods for detecting
these contaminants. Newly developed methods of analysis are intended both for screening
purposes (rapid, economic and simple methods) and for the accurate, reproducible and sen‐
sitive quantification by confirmatory methods.
Numerous chromatographic methods to detect AFs in foods have been developed, coupled
to fluorescent or mass spectrometric detection [9-11]. Likewise, several methods for aflatoxin
M1 determination in milk based on high-performance liquid chromatography associated to
fluorescence or mass spectrometric detection have been developed [12-13]. However, chro‐
matographic techniques are mainly used in confirmatory analyses and are usually not ap‐
plied to routine controls owing to the necessity to use expensive equipment and extensive
clean-up steps.
The first rapid methods of analysis for AFs were based on Thin Layer Chromatography [14];
this technique is still used today even though in a significant lesser extent compared to
methods based on the use of antibodies. Immunochemical methods of analysis are widely
employed as screening methods for measuring AFs in food and feed [9, 14-18] and also for
AFM1 quantification in milk and dairy products [19-21] thanks to their rapidity, selectivity
and sensitivity. Several ELISA kits are commercially available, whose performances are gen‐
erally adequate to meet legal requirements, and are routinely employed for aflatoxin moni‐
toring. Some of these methods have also been validated [17-18]. However, even
immunoassays need to be run in a laboratory, use a minimum of equipment and occasional‐
ly require some sample treatments, which may also involve the use of hazardous chemicals.
Instead, affordable monitoring of food contaminants requires the highest-through put and
more economical methods of detection and, possibly, little or no sample treatment, user-
friendliness, employment of non-hazardous chemicals, in situ applicability. Additional
requisites in aflatoxin detection would be low detection limits (especially for aflatoxin M1)
and adaptability to very differing commodities (for aflatoxins B and G).
Several innovative strategies have been proposed for the rapid, qualitative, semi-quantita‐
tive or quantitative detection of aflatoxins, also based on the use of specific antibodies with‐
out constraints of classical immunoassays [22]. For example, an interesting qualitative
approach has been described for the detection of AFM1 in milk [23-24]. The proposed meth‐
od is based on a flow-through immunoassay with visual detection. Main advantages are
represented by the high sensitivity and by the on site applicability of the assay which does
not require any equipment for the treatment of the sample, norfor the analysis. In addition,
it allowed the possibility of obtaining sample pre-concentration and/or clean-up in the same
device used for the analysis [25]. Nevertheless, this method implies several subsequent steps
to be carried out, thus limiting simplicity and rapidness of use. Very recently, the same ap‐
proach has also been demonstrated for the multi-detection of different mycotoxins, thus in‐
creasing its potentiality of utilization [26].
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Numerous immunosensors have been described [27] as well, and research is constantly
evolving in this area, particularly for the development immunosensors for the selective de‐
termination of AFB1 [28-32] and for AFM1 detection [33-35].
In parallel, strategies aimed at avoiding the use of antibodies in the development of rapid
methods for aflatoxin detection have also been reported, such as those based on the prepara‐
tion of polymers with molecular recognition properties towards AFB1as capture systems
[36-37] or those based on the exploitation of its natural fluorescence for the detection [38]. A
combination of the surface plasmon resonance phenomenon and fluorescence has been ex‐
ploited in the work of Wang et al and permitteda very sensitive determination of AFM1,
though the proposed assay took almost an hour to be accomplished and couldn't be consid‐
ered as a truly rapid method [39]. A fancy and cunning approach for the rapid quantifica‐
tion of AFB1 have been described in the work of Arduini et al, who exploited the inhibiting
effect of the toxin towards the enzyme acetylcholinesterase. The measurement of the enzy‐
matic activity was demonstrated to directly allow AFB1 quantification in 3 minutes and
within the 10-60 μg l-1 range [40].
Among the rapid methods for screening of food contaminants, the'lateral flow immunoas‐
say” (LFIA) (also known as immunochromato graphic assayorimmuno-colloid gold immu‐
noassay, ICG) has recently attracted the interest of researchers and industry. This
technology has long been known in medical fields for diagnosing blood infections and fail‐
ure of internal organs, disclosing drug abuse or ascertaining pregnancy and combines a ser‐
ies of benefits, including extreme simplicity, rapidity, and cost effectiveness [41]. These
features make it ideally suited for screening large number of samples, for being conducted
by non-trained personnel and practically everywhere, thus enabling the effective possibility
of food safety assessment at all stages of food and feed production.
2. Lateral flow immunoassays for aflatoxins
Since the early 2000's, scientific papers and commercial devices aimed at measuring myco‐
toxinsin food and feed have appeared, and recentlya certain amount of literature on this
topic has become available, including comprehensive reviews [42-44]. In particular, some
LFIAs for the qualitative and semi-quantitative detection of aflatoxins in food and feed have
been described and will be discussed below. At the same time, commercial LFDs for the de‐
tection of aflatoxinsin various commodities have become available and some of them have
also been validated by USDA-GIPSA [45].
2.1. Principle of the method
As aflatoxins are low-molecular-mass compounds, immunoassays in competitive formats
should be conceived to measure them. The same principles and reagents as in the micro‐
well-type immunoassays could be applied, except for the fact that,in LFIA, the separation of
bound and unbound antibody sites is obtained by means of the lateral flow on a suitable
support (the membrane). The liquid flow transports immunoreagents along the membrane
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where they encounter their partners in spatially confined zones of the membrane itself
where immuno reactions take place.
Besides the porous membrane which assures the flow, lateral flow devices (LFDs) usually
include: an absorbent pad (positioned at the top of the membrane to increase the volume of
the flowing liquid), a sample pad (to assure contact between the liquid sample and the
membrane), and a rigid backing (Figure 1). A release pad can be added, whose role is to ad‐
sorb labelled antibodies in such a way that they are included in the device itself.
The membrane is almost exclusively made of nitrocellulose (NC); sample and adsorbent
pads are usually made of cellulose, although sample pads could also be made of glass fibre
or other materials and sometimes are soaked with proteins and/or surfactants for special ap‐
plications. Release pads are usually glass fibre pads. Lines are traced on the NC membrane
by means of dedicated dispensers which enables the dispensing of small volumes (typically
few μl per cm) with high reproducibility.
Figure 1. Schematic of a lateral flow device in the dipstick format.
The simplest LFD is a dipstick, which is dipped directly into the sample solution. Labelled
antibodies can be added to the sample as a concentrated suspension or provided in a lyophi‐
lized form to be re-suspended by the sample itself. Alternatively, the labelled antibody can
be pre-adsorbed onto the releasing pad, which partially overlaps the membrane. The liquid
sample itself causes the re-suspension of the pre-adsorbed labelled antibodies during the as‐
say. The sample pad is added in such a way that it overlaps the membrane or the releasing
pad. Its role is the reduction of matrix interference by filtration alone or combined with
some chemical action by means soaked reagents.
Besides the most popular dipstick format, LFDs exist in which the strip is inserted into a rig‐
id plastic cassette provided with a sample well and a reading window. The main advantage
of these housings is the guarantee of a reproducible compression of all components in the
overlapping zones, which assures faster and more reproducible flows.
With few exceptions, the indirect competitive format, in which the antigen (a protein conju‐
gate of the target toxin) is coated on the membrane and the antibody is labelled, is strongly
preferred in the development of LFIA for AFs. Antibody labelling can be obtain by using
virtually whatever nanoparticles that have a spectroscopically detectable property, such as,
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for example, coloured or fluorescent nanoparticles. However, gold nanoparticles (GNPs) are
generally employed, with few exceptions, because of some characteristics which make them
particularly suitable for the purpose. First, the conjugation of antibodies with GNPs is very
easily obtained by simply mixing the two components at a proper pH (at or above the pI of
the antibodies). The preparation and characterisation of stable colloidal solution of GNPs al‐
so follows well-established, easy protocols and a wide literature is available on this topic.
The surface plasmon resonance of GNPs determines an intense colour of colloidal gold,
which varies from orange to pink depending on particle dimensions and on surface overlay,
therefore coloured nanoparticles can be prepared and the colour nuance can be use to moni‐
tor preparation and conjugation to antibodies.
The principles of the indirect competitive LFIAs which exploit GNP-labelled antibodies
have been widely described and are schematized in Figure 2 and 3.
Briefly, the labelled specific antibody is suspended in the liquid sample and flows through
the membrane where it first encounters the antigen coated in a zone indicated as “Test line”
(T-line). In the absence of the target compound (negative sample, Figure 2), labelled antibod‐
ies bind to the coated antigen and are focused on the T-line, so that a visible (detectable) line
is formed.
Usually, a second so-called “Control line” (C-line) follows and is constituted by secondary
anti-species antibodies which capture any excess of specific antibodies.
Figure 2. A lateral flow immunoassay in the indirect formatwith GNP-labelled antibodies for a negative sample (no AF
is present). The Test line is made by a protein conjugate of the target toxin, while the Control line is constituted of
anti-species antibodies. Anti-aflatoxin antibodies mixed together with non-specific γ-globulins (both GNP-labelled)
move along the membrane. Anti-AF antibodies bind the antigen coated in the Test zone and are focused, thus form‐
ing a visible (detectable) line. Non-specific γ-globulins pass the Test line and are captured by the anti-species antibod‐
ies in the Control line where they are focused and form a second visible (detectable) line.
The appearance of a C-line can be regarded simply as the confirmation of the correct devel‐
opment of the assay (reagents and materials integrity) or else can be exploited to calculate
the T/C signal ratio with the aim of normalizing strip-to-strip variations [46] or can also be
regarded as an internal standard to which the intensity of the T-line is compared to deter‐
mine positivity/negativity [47-48].
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When the target is present above the lower detectable concentration level (positive sample,
Figure 3), binding of labelled antibodies to the coated antigen is inhibited, resulting in a
non-visible (undetectable) T-line.
Interpretation of assay results depends on the presence and intensity of both Test and Con‐
trol lines as schematized in Figure 4.
Figure 3. A lateral flow immunoassay in the indirect format for a positive sample (AF above the detectable limit). GNP-
labelled anti-aflatoxin antibodies and non-specific γ-globulins move along the membrane. Anti-AF antibodies bind the
toxin in the sample and the interaction with coated antigen is thus inhibited. Non-specific γ-globulins pass the T-line
and are captured by the anti-species antibodies in the Control line where they are focused. Therefore, a single line (C-
line) appears on the membrane.
Figure 4. Assay result interpretation. Two intense lines: valid test, negative sample (target toxin below the detection limit
of the method); intense C-line and fading T-line: valid test, the amount of the target toxin is near to the detection limit;
intense C- line: test valid, positive sample (target toxin above the detection limit); intense or fading T-line: invalid test.
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2.2. LFIAs for aflatoxins B and G
The first LFIA aimed at measuring any one of aflatoxins appeared in the scientific literature
ten years ago and was one of the first reported lateral flow assays for food contaminants.
The authors described a simplified device formed by aNC membrane on which the T-line
had been traced upon by dispensing antibodies towards AFB1. The signal reporters were lip‐
osomes, which were tagged with AFB1 and encapsulated a visible dye. The tagged lipo‐
somes flowed along the membrane where encountered the coated anti-AFB1 antibodies and
were captured, thus determining the appearance of a coloured T-line due to the focalization
of the encapsulated dye. If some AFB1 was present in the sample, the binding of the tagged
liposomes to the coated antibodies was inhibited and the colour of the T-line faded. The ab‐
solute limit of detection of such a device was 18 ng of AFB1 and the test could be completed
in a total of 12 minutes, including sample preparation [49].
Apart from this early approach, following papers described more usual LFDs based on the
use of GNPs as antibody labels. In 2005, Delmulle and co-workers reported the development
of a dipstick which allowed authors to detect AFB1in pig feed. The visual detection limit
(VDL) was set at 5 μg kg-1 and the analysis could be completed in 10 minutes [50]. In the
same year, the group of Xiulianal so described the preparation of GNP-labelled antibodies
towards AFB1 and their exploitation in a visual LFIA [51]. The application of the developed
dipstick to measure AFB1 in rice, corn, and wheat was reported in a following paper of the
same group [52]. The described LFD showed a VDL of 2.5 μg l-1 in buffer, which became 0.05
μg l-1 when the colour intensity of lines was determined by means of a photometric reader.
Therefore, a sensitive quantification of the target toxin (limit of detection, LOD, 2 μg kg-1 in
food) could be demonstrated; moreover, accuracy of the developed assay was confirmed on
60 samples through comparison with ELISA.
A visual LFIA for detecting AFB1 was also described by papers of Shim et al [53-54]. The de‐
veloped LFD was shown to cross-react to some extent to other major aflatoxins (AFB2, AFG1,
and AFG2) but not to differing mycotoxins (such as ochratoxin A, citrinine, patulin, zearale‐
none, and T-2 toxin). Nevertheless, it was applied for selectively measuring the sole AFB1in
rice, barley and feed. VDLs of 5-10 μg l-1(rice, barley) and 10-20 μg l-1(feed) were obtained
and the proposed method showed agreeing results towards HPLC analysis on up to 172
food and feed samples. The same group also published results obtained with a multi-analyte
device aimed at contemporary measuring AFB1 and ochratoxin A in feed. The described
method allowed the simultaneous detection of the two toxins which could be completed in
15 minutes and showed a VDL of 10 μg kg-1for AFB1. Method validation by means of ELISA
and HPLC confirmatory analyses was also reported [55].
Although regulations prescribe the simultaneous determination of AFB1, AFB2, AFG1, and
AFG2 beside AFB1 quantification, most papers described LFIA selective towards AFB1.To
meet the need of measuring all the four major AFs our group developed a quantitative LFIA
for total aflatoxin determination in corn samples. The assay could be completed in 10 mi‐
nutes, showed a LOD of 10 μg l-1 and was validated through comparison with HPLC on 25
samples. In addition, an aqueous extracting medium was also optimized and proven to al‐
low reliable quantification of total aflatoxin [56]. Except in this case, AFs were always ex‐
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tracted in methanol/water (typically 70/30 or 80/20 v/v) followed by dilution of the extract
before LFIA analysis to reduce the proportion of the organic solvent, which is hardly com‐
patible with materials composing LFDs. However, a methanol amount lower than 15-20%
has been demonstrated by most authors to be compatible with LFD materials and further
more not to affect immunoassay performance.
Most recent contributes to the topic are due to the group of Zhang and co-workers, who de‐
scribed two LFDs, the first highly selective towards AFB1 and the second able to measure
total aflatoxins [57-58]. Both devices have been applied to visually detect target toxins in
peanuts (the highly selective one could also be exploited to detect AFB1 in pu-erh tea, vege‐
table oil and feed). Both methods allowed reliable results (agreeing with HPLC determina‐
tion) to be obtain in 15 minutes. In addition, the LFIA aimed at measuring total AFs was
extremely sensitive, with VDL in peanut extracts as low as 0.03, 0.06, 0.12, and 0.25 μg l-1for
AFB1, AFB2, AFG1, and AFG2, respectively.
In addition to papers aimed at describing actually functioning devices for measuring AFs,
those targets have often been chosen as system models for the development of original devi‐
ces which exploited non-traditional signal reporters to label antibodies. Besides the above
mentioned approach of Ho and Wauchope, based on the use of dye-encapsulating lipo‐
somes, Liao and Li described a visual device which exploited nanoparticles with a silver
core and a gold shell as the reporters in the construction of a LFD for AFB1. The toxin was
determined in cereals and nuts and performances were compared to those of a GNP-based
LFIA and to results obtained through a classic microwell-based immunoassay. The authors
demonstrated that the newly developed LFD was comparable to the GNP-LFD in terms of
stability of components and reproducibility of signals. On the other hand, it allowed a great
enhancement in sensitivity so that values as low as 0.1 μg l-1AFB1 could be measured [59].
With the expectation of increasing the useful signal, therefore being able to reduce immu‐
nore agents for the benefits of the competition, magnetic nanogold microspheres with a
Fe2O3 core and a shell of multiple GNPs have also been proposed. The magnetic core of par‐
ticles allowed authors to simplify separation steps during the labelling of antibodies and
their micro- dimensions to enhance colour during the test itself. A three-fold increase in sen‐
sitivity was stated for the visual detection of AFB2 compared to the use of simple gold col‐
loid nanoparticles [60].
2.2.1. Application of LFIA for aflatoxins B and G in food analysis
A major concern in the development of LFDs for aflatoxins is the unpredictable effects due
to food components co-extracted from the sample beyond the target and which affect not
only the antigen-antibody interaction on which the immunoassay is based, but also the me‐
chanics of the device itself.
Some authors experienced the apparently inexplicable failure of recovery experiments con‐
ducted on fortified materials and the incongruity of results attained for artificially and natu‐
rally contaminated samples, which necessitate matrix-matched calibrations and
recommended the use of naturally contaminated samples blended in varying proportions
Aflatoxins - Recent Advances and Future Prospects322
with blank samples as calibrators [56, 61-63]. Matrix components not only interfere in defin‐
ing appropriate standards for calibration but also determine requirement of distinct devices
to be developed for individual foods.
Despite the fact that the some authors reported calibration by using standard AFs diluted in
buffers (to which methanol is added in limited proportions, as discussed above) and stated
no interference from matrix given a limited dilution of sample extracts, the application of
LFDs for the effective AF B and G detection in food remains the bottleneck in the develop‐
ment of new LFIAs. This taskis also made particularly complex by the multiplicity andvari‐
ety of matrices to be considered in aflatoxin B and G analysis.
2.3. LFIAs for aflatoxin M1
The development of LFIAs for AFM1 is one of the most challenging goals in this field of re‐
search because of the extreme sensitivity required by legislation for this contaminant (partic‐
ularly in the European Union).
The first paper dealing with the subject reported a validation study on a commercial device
which was conceived for meet US regulations and did not described any preparation proto‐
cols and methods. The ROSA Charm Aflatoxin M1™ aimed at quantitatively measuring
AFM1 in milk was validated as the result of an inter-laboratory trial, which involved 21 par‐
ticipants, at four levels above and two below the declared LOD of the assay (400 ng l-1) [64].
Less than 5% of false negative (n=83) and no false positive below 300 ng l-1 were found. For
contaminations between 350 and 450 ng l-1 false positivity increased from 21 to 93%.
More recently, Wang et al first described the development of a LFD for the detection of
AFM1  [65]. The cut-off level (0.5-1 μg l-1) is just above the eligible value required by the
US regulation [8]  and far  beyond the more severe limits  imposed by the European Un‐
ion for this contaminant [2]. However, it is an effectively sensitive and rapid assay, provid‐
ed  that  the  whole  analytical  procedure  can  be  completed  in  10  minutes,  as  no  sample
treatment is required.
A visual device has also been developed by Zhang et al which showed a VDL for AFM1of
0.3 μg l-1 [66]. Although the sensitivity improvement respect to the work of Wang et al, the
obtained VDL remains far away from the detectability demand imposed by EU MRLs for
this contaminant.
3. Development of a highly sensitive LFIA for measuring AFM1 in milk
With the aim of producingasystem sensitive enough to reach the limits imposed by Europe‐
an regulations, we developed a competitive lateral flow immunoassay which exploited rab‐
bit polyclonal antibodies towards AFM1that had been previously employed in the
development of a sensitive ELISA [19]. A classic device, including a NC membrane (onto
which the two lines of reagents had been immobilized), cellulose sample and adsorbent
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pads, and a glass fibre release pad (on which GNP-labelled antibodies are pre-adsorbed)
was conceived.
The method was designed to be a competitive LFIA, in which the Test line comprised an
AFM1 conjugate (competitor) and the Control line was composed of anti-rabbit IgG antibod‐
ies. GNP-labelled anti-AFM1 antibodies were furnished as pre-adsorbed in a release pad.
When re-suspended by the sample, flowed across the membrane where first encountered
the T-line and bound to the immobilized AFM1 conjugate. A red colour became visible at the
T-line, due to the focusing of nanoparticles. If some AFM1 was present in the sample, it com‐
peted with the immobilized AFM1-BSA for binding to the GNP-labelled antibodies, resulting
in a reduction of the T-line intensity. The anti-rabbit IgG antibodies on the Control line cap‐
tured any excess GNP-labelled antibodies to produce a C-line as a visible confirmation of
particle flow. Signal intensities of the two lines were read by a portable scanner connected to
a laptop and processed by dedicated software, which acquires images, determines colour in‐
tensity, interpolates values on a memorized standard curve and returns the concentration of
the analyte in the sample.
Since the methodin development was a competitive immunoassay, its sensitivity was influ‐
enced by several well-known factors, such as antibody dilution and competitor concentra‐
tion, provided that a definite antiserum was used. Additional factors that could be
considered were: the chemical structure of the hapten (actually, the use of heterologous
competitors had been shown to improve sensitivity [67]), the structure of the antigen used
as the competitor in the assay (as far as the nature of the carrier-protein and the degree of
conjugation between the hapten and the carrier-protein itself were considered); the specific
response of the reporter used to label the antibody; the extent of antibody labelling (moles of
reporter per mole of antibody). In effect, the work of Byzovaet al [68] firstly reported the ef‐
fect of varying some of the described factors on LFIA performances and, in particular,
showed that the diminishing of the molar substitution ratio (SR) between the hapten and the
carrier-protein in the preparation of the competitor significantly improved as say sensitivity.
The same authors also studied the binding capacity of different anti-species antibodies
(which were used to trace the C-line) concluding, in this case, that no evident differences
could be observed.
The need of developing a very high sensitive assay for determining AFM1 in milk at lev‐
els of regulatory concern according to EU regulation [2],  forced us to investigate further
in these directions and to question other established practices, such as the assumption that
the labelling of antibodies should be conducted in such a way to obtain a complete coat‐
ing of GNP surfaces.
Therefore, the effects of varying: the competitor (use of homologous or heterologous hapten;
nature of the carrier-protein and hapten-to-protein molar ratio) and the reporter (extent of
antibody labelling)on sensitivity were studied and optimized.
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3.1. Materials and methods
3.1.1. LFD preparation
Gold colloids with mean diameter of about 40 nm were prepared using the sodium citrate
method as previously described [46]. The saturation concentration of the anti-AFM1 anti‐
body for conjugation with gold nanoparticles was determined according to Horisbergand
Rosset [69]. GNP-antibody conjugation was carried out using an amount of antibodies
which is the half the saturation concentration and was carried out as follows: 100 μl of a 0.5
mg ml-1 anti-AFM1antibodies in borate buffer was added to 10 mL of pH-adjusted colloidal
gold solution. After 30’ incubation at room temperature, 1 ml of borate buffer containing 1%
of BSA was added. The mixture was centrifuged and the pellet was washed twice by re-sus‐
pension in borate buffer with 0.1% BSA added. Finally, the pellet was re-suspended in bo‐
rate buffer supplied with 1% BSA, 0.25% Tween 20, 2% sucrose, and 0.02% sodium azide
and stored at 4°C until use.
Release pads were previously treated with borate buffer supplied with 1% BSA, 0.25%
Tween 20, 2% sucrose, and 0.02% sodium azide. After drying, gold-labelled antibodies were
distributed near the lower edge of the pads and left to dry.
Test and Control lines were spotted upon a NC membrane as follows: the AFM1-protein
conjugate (SR 4) at 0.3 mg/ml was the capture reagent, and the goat anti-rabbit IgG antibod‐
ies (2 mg/ml) formed the C-line. Then, the membrane was dried. Strips were composed as
follows: from the top; the adsorbent pad, the NC membrane, the release pad and the sample
pad were pasted, in sequence, with 1-2 mm overlap. Release pad was positioned so that the
line of GNP-labelled antibodies was on the opposite site from the edge of the membrane. The
prepared membrane was cut into strips of 5 mm, which were inserted into rigid plastic cassettes.
Cassettes were stored in plastic bags containing silica at room temperature until use.
3.1.2. Lateral flow immunoassay procedure
Pasteurized milk samples were purchased in large stores, and raw milk samples were ob‐
tained from farms. Whole and semi-skimmed milk (1 ml) were centrifuged for 2 min at 6000
rpm. The upper fat layer was discharged, 500 μl of the underlying serum was transferred
into a tube and 25 μl of 10% Tween 20 was added. The mixture was immediately used in the
lateral flow assay.
The test was carried out by placing 100 μl of sample into the sample well. After 15 minutes
of incubation at 37°C, the cassette was placed above a mobile scanner connected to a laptop.
The Skannex 3.0 software (SkannexAS,Hoenefoss, Norway) was used to acquire and process
images. Calibration curves were obtained by plotting the ratio between the intensity of the
test (T) and the control line (C) [46] against the log of AFM1 concentration. For each experi‐
ment, a calibration curve was determined by a nonlinear regression analysis of the data us‐
ing the four-parameter logistic equation [70]. For the construction of the standard curve and
for recovery experiments blank milk samples that did not show any detectable residues of
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the target when analysed by a reference ELISA (LOD 5 ng l-1) [19] were fortified with appro‐
priate amounts of an AFM1 standard solution.
3.2. Optimization of the LFIAs
3.2.1. Effect of varying the hapten, the AFM1-protein substitution ratio and the carrier protein in theT line
The  polyclonal  antiserum  used  in  this  work  had  showncertain  cross-reactivity  towards
aflatoxin B1  (about 35% when measured by means of the ELISA); therefore a competitor
synthesized  by  using  a  hapten  derived  from  this  toxin  was  considered  as  a  “heterolo‐
gous” competitor respect to AFM1 protein conjugates (which were homologous to the im‐
munogen).  Therefore,  three  conjugates  of  AFM1  with  Bovine  Serum  Albumin  (AFM1-
BSA) conjugates which varied in the hapten-to-protein ratio, one conjugate of AFM1with
ovalbumin (AFM1 –OVA) and one conjugate between AFB1and BSA (AFB1-BSA) were eval‐
uated as potential  competitors to be immobilized in the Test  line (Table 1).  Each conju‐
gate was dispensed on the membrane at the same rate and volume (1μl/cm), however the
concentration was varied to obtain an absolute signal of about 20-25 arbitrary units in the
T-line  when  the  strip  were  read  by  means  of  the  software.  AFM1  standard  solutions
(0-10-100-1000 ng l-1) prepared in a blank pasteurized whole milk were measured in tripli‐
cate and IC50  values were compared (Table 1). The AFB1  conjugate qualitatively behaved
as the AFM1  conjugate with a similar SR, except for the absolute signal,  which was less
intense at the same concentration of dispensing. Interestingly, the decrease of the amount
of AFM1  per mole of protein strongly influenced the sensitivity of the assay. Indeed, the
reducing of the substitution ratio (SR) from about 22 to about 4 allowed an improvement
of  nearly 10-folds in  the IC50  to  be  obtained.  This  result  is  in  good agreement  with the
observation  of  Byzova  and co-workers  [68]  and with  expectations  based  on  the  experi‐
ence with competitive immunoassays in other formats (such as for example in ELISA). In
parallel, the absolute signal decreased and forced to increase the amount of antigen to be
dispensed. Nevertheless, the advantage of reducing the hapten density strongly predomi‐
nated over the increase of the absolute antigen concentration.
Conjugate SR Dispensing concentration (mg ml-1) IC50 (µg l-1)
AFM1-BSA 4 0.8 0.2
AFM1-BSA 15 0.4 1.1
AFM1-BSA 22 0.2 1.7
AFM1-OVA 10 0.8 0.6
AFB1-BSA 24 0.4 1.6
Table 1. Effect of varying the competitor to be used in the Test line of the LFD. Protein conjugates were dispensed
onto the membrane at different concentrations to reach an absolute signal comprises between 20 and 25 arbitrary
units on the T-line. SR represents the molar substitution ratio between the toxin and the protein which had been
estimated by spectrophotometric measurements.
Aflatoxins - Recent Advances and Future Prospects326
On the contrary, the substitution of the bovine serum albumin (which had been used to pre‐
pare the immunogen) with ovalbumin as the carrier-protein seemed irrelevant. In fact, anti‐
bodies binding the BSA used as the immunogenic carrier-protein are saturated in the
preparation of the gold labelled- antibody. This preparation involves the GNP overcoating
with exceeding amount of BSA to prevent aggregation; however, the inhibition of further
non-specific binding to BSA of antigens could also be attained.
3.2.2. Labelling of antibodies with gold nanoparticles
Optimization of LFIA usually involves checkerboard titrations where the amounts of anti‐
bodies and of  the competitor are varied to achieve the lower limit  of  detection and the
maximum slope of the calibration curve. Varying the amount of antibodies is exclusively
intended as diluting the colloid of GNPs coated with antibodies themselves. The parame‐
ter used to measure this dilution is the optical density (OD) of the gold colloid, assuming
that GNPs surface had been saturated with antibodies; a typical protocol prescribes that the
saturation amount of antibodies, intended as the amount that prevent GNP aggregation, has
to be determined firstly and this  stabilizing amount or,  more usually,  a  small  excess of
antibodies, has to be conjugated to GNPs to prepare the signal reporter. Nevertheless, con‐
trarily  to  this  generally  accepted assumption,  Laycock et  al  reported a  huge increase in
sensitivity due to the reduction of antibodies coated onto GNPs in comparison to the stabi‐
lizing amount [47].
Therefore, besides studying the effect of varying GNP-labelled antibody (intended as vary‐
ing the OD under saturating conditions); we considered that dilution of antibodies to favour
competitive conditions would also be achieved by reducing the number of molecules of anti‐
body bound per GNP at a fixed OD value. Consequent risk of GNP aggregation, due to in‐
complete shielding of the superficial GNP charges, could be efficiently prevented by the
further addition of exceeding amount of other proteins, such as for example BSA, which is
particularly effective in this purpose.The variation of the amount of GNP-labelled antibod‐
ies dispensed at different ODs (3 and 6) under saturating conditions, apparently did not di‐
rectly influence the sensitivity of the LFIA (data not shown) Nevertheless, the increasing of
the OD allows the development of more intense absolute signals, which in turn means that
the amount of competitor could be decreased in the T-line therefore improving detectability.
To study antibody dilution intended as the reduction of antibody amount per GNP, differ‐
ent amount of antibodies were reacted with portions of the same GNP colloid as follows:
saturation amount (AbSAT), excess of antibody (Ab/ AbSAT = 1.5), defect of antibody (Ab/
AbSAT = 0.7), and half the saturation amount (Ab/ AbSAT = 0.5). The four GNP-antibody prep‐
arations were dispensed onto release pads at OD 3 and applied to strips where the AFM1-
BSA with SR of 22 and a concentration of 0.2 mg/ml had been traced upon to form the T-line.
AFM1 calibrators prepared in milk were run onto these strips in triplicate. Resulting curves
are show in in Figure 4. Besides a significant signal reduction, a certain improvement in sen‐
sitivity was observed when the amount of antibody was lowered from saturating conditions
(IC50 = 1.71 ± 0.01) to its half (IC50 = 0.99 ± 0.01); however detectability was influenced in a
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considerably lesser extent respect than when modifying the nature of the competitor (i.e.:
the SR of the conjugate used to obtain the T-line), as discussed above.
Figure 5. Effect of the amount of antibodies coated onto the GNPs (Ab) compared to the amount needed for saturat‐
ing GNP surface (AbSAT)for varying Ab/ AbSAT: 0.5 (฀), 0.7 (▲), 1 (฀), 1.5 (฀).GNP-antibodies dispensed at OD 3; T-line:
AFM1-BSA conjugate (0.2 mgml-1, SR=22).
3.3. AFM1 detection in milk by the developed LFIA
Protein and fat contents of milk may influence test results in various ways: the sample flow
can be altered (for example fat content strongly affectsviscosity) and any of the milk compo‐
nents can give specific or non-specific interactions with immunoreagents involved in the as‐
say. In fact, we observed that casein determined a strong signal depression of both the Test
and Control lines. With the aim of developing a unique system that could be used on milk
samples undergone to different thermal treatments, i.e.: with different levels of protein de‐
naturation (raw, pasteurized, UHT milk) and with variable fat content (whole, semi-skim‐
med, skimmed milk), samples were standardized by a rapid centrifugation stepto allow the
removal of the fat layer and by adding Tween 20 to control protein interferences.
After development (15’ at 37°C), strips were scanned. Dedicated software acquires and proc‐
essed images and the signal, intended as the T/C ratio, was plotted against the logarithm of
AFM1 concentration to carry out calibration. As previously observed in the development of
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LFIA for other mycotoxin [56, 61-63], matrix-matched calibration should be carried out to fit
experimental results obtained on milk samples. Therefore, a pasteurized whole milk sample
in which AFM1 was found out undetectable when analysed by the reference ELISA kit was
used to prepare diluted calibrators. A typical calibration curve is depicted in Figure 5. A
LOD (calculated as the average of the blank minus 3 standard deviations from the average)
and IC50 of 20 ng l-1 and 102 ± 19 ng l-1 were estimated, respectively.
Figure 6. A typical calibration curve for AFM1 measurement in milk by the developed LFIA. Error bars represent SD of 3
replicates.
Accuracy of the developed LFIA was evaluated on different kind of milk samples (Table 2).
Milk samples were purchased on the market and were found undetectable according to the
developed LFIA. Therefore, accuracy was evaluated on samples fortified at two levels (50
and 100 ng l-1). Acceptable results were obtained, although a slight overestimation or under‐
estimation were observed for the raw and the UHT samples, respectively, which can be at‐
tributed to the fact that calibration was carried out in pasteurized milk.
The intra- and inter-day precision was evaluated at 3 levels of fortification (0-50-100 ng l-1).
RSD  values  were  generally  high  (above  30%)  which  makes  reliability  of  quantification
questionable.
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Milk sample AFM1 measured byELISA (ng l-1)
Fortification level (ng
l-1)
Estimated AFM1± SD
(ng l-1) Recovery (%)
raw 17.8 0 <LOD
50 78.4 ± 6.2 121
100 153.2 ± 14.1 135
whole 1 < LOD 0 <LOD
50 40.0 ± 2.0 80
100 121.5 ± 9.8 122
whole 2 16.0 0 <LOD
50 79.0 ± 8.6 126
100 125.5 ± 11.0 126
skimmed 15.7 0 34.6 ± 1.2
50 74.4± 4.0 117
100 113.0 ± 20.5 97
UHT <LOD 0 <LOD
50 46.8 ± 5.3 94
100 87.5 ± 10.8 88
Table 2. Recovery of AFM1 determination from artificially contaminated milk samples undergone to various thermal
treatments and with different fat content as determined by the developed LFIA. Recovery was calculated as follows:
(estimated AFM1 for the fortified sample – estimated AFM1 for the non fortified sample) / fortification level *100
3.4. Intra-laboratory validation of the semi-quantitative LFIA
The objective  of  analytical  methods  such as  those  based on the  LFIA technology is  the
parting between samples surely complying with legislation in force and samples which do
not comply. However, a further category of samples should be considered and is represent‐
ed by those samples in which the toxin content is close to the legal limit which because
of measure uncertainty cannot be classified as compliant or noncompliant (Figure 4). These
“uncertain samples” should be submitted to further controls before entering the transfor‐
mation chain. In the case of milk, rejection is more often the fate of such uncertain sam‐
ples (as for noncompliant samples), because the perishable nature of milk discourages time-
consuming investigations. Therefore, the purpose of the work could become the development
of a very rapid screening method which allowed the semi-quantitation of AFM1 in milk in
such a way to permit the discrimination between compliant and noncompliant samples.
The instrumental quantification of coloured lines and their correlation with a calibration
curve, in this context,  could be regarded as a way to limit subjectivity in the interpreta‐
tion of results and to improve detectability [52, 44] rather than going into the direction of
factual quantitative measurements.
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To achieve the useful ability to discriminate compliant from noncompliant samples, a prop‐
er cut-off value should be established. The eligible EU MRL value (i.e.: 50 ng l-1) would be
expected to be at tain able given the high sensitivity of the developed LFIA. Nevertheless, the
definition of a cut-off level should consider precision and technical limitations of the meth‐
od, besides sensitivity. Moreover, the calibration curve being a continuously descending curve
characterized by a finite slope, the definition of a single-point cut-off value is less appropri‐
ate than the identification of an indicator range of analyte concentrations within which uncer‐
tain or “non-attributable” results (neither “compliant” nor “noncompliant”) fall [44].
As regard precision, European legislation for screening methods of analysis defines as appro‐
priate a relative uncertainty of 47% of the MRL and as acceptable even 94% for AFM1 based
on the application of Horwitz equation [71]. Accepting the more restrictive criterion, this means
that any screening methods should be able to discriminate between AFM1 content less than
26.5 ng l-1 (negative sample) and AFM1 content over 73.5 ng l-1 (positive sample). Samples that
have AFM1 content close to the thres hold limit should thus be defined as uncertain because
precision did not allow to reliably attributing them to one or another group.
In spite of this, it should be noted that a “non-attributable” judgement would determine re‐
jection of the sample with a considerable economic damage, as discussed above. Therefore,
the minimum number of non-attributable results would be expected for a worth while meth‐
od and this number obviously depends on the combination of accuracy and precision of the
method itself. To indicate the capability of a qualitative/semi-quantitative method to pro‐
duce the lowest score of non-attributable results, for a defined uncertainty interval, we intro‐
duced a new parameter indicated as “efficiency” of the method, defined as the ability of the
method itself to detect truly non-attributable as non-attributable. Efficiency was thus calcu‐
lated as the number of truly non-attributable tests divided by the sum of known non-attrib‐
utable samples, in strict analogy with “sensitivity” and “selectivity” of qualitative and semi-
quantitative as says, which are defined as the rate of truly positive e and truly negative test
results, respectively [50, 60]. The more efficient the assay, the highest the score of useful re‐
sults (samples certainly attributed as compliant or noncompliant).
The ability of the developed LFIA to correctly attribute to each of the groups milk samples
found on the market was thus assessed; in particular, negative (compliant) samples were de‐
fined as those in which AFM1 content was below 30 ng l-1, positive (noncompliant) samples
those in which AFM1 content was above 70 ng l-1 and uncertain (non-attributable) those hav‐
ing an AFM1 content between 30 and 70 ng l-1. Since all tested samples were always contami‐
nated below 30 ng l-1 as established by the reference ELISA, positive samples were generated
through fortification at 50 and 100 ng l-1. Results of this evaluation, together with the defini‐
tion of sensitivity, selectivity and efficiency, are reported in Table 3.
It can be observed from data that the definition of an indicator range instead of a cut-off lev‐
el allowed us to avoid occurrence of false compliant and false noncompliant. Incorrect attri‐
bution occurred in 15% of samples (6/40), though 3 of them would represent a minor issue
being assigned as non-attributable rather than noncompliant, which anyhow mean that sam‐
ples would be discarded. The efficiency is relatively low, however it could still be consid‐
ered acceptable.
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Parameter Definition Calculated as Value (%)
Sensitivity truly positive / known
positive
tp / (tp + fn + fup) 81.3
Selectivity truly negative / known
negative
tn / (tn + fp + fun) 100.0
Efficiency truly uncertain / known
uncertain
tu / (tu + fun + fup) 62.5
False compliant rate false negative / known
negative
fn / (tn + fn + fun) 0
False noncompliant rate false positive / known
positive
fp / (tp + fp + fup) 0
False non-attributable rate false uncertain / known
uncertain
fu / (tu + fun + fup) 37.5
Table 3. Evaluation of LFIAs performances on 40 milk samples: 16 negatives, 16 positives and 8 uncertain. The AFM1
reference content was determined by an ELISA kit [19]. Abbreviations used: tp, truly positive (AFM1 below 30 ng l-1);
tn, truly negative (AFM1 above 70 ng l-1); tu, truly uncertain (AFM1 between 30 and 70 ng l-1); fn, false negative; fp,
false positive; fun, false uncertain and known to be negative; fup, false uncertain and known to be positive.
Finally, the stability of the overall device at room temperature was evaluated as the possibil‐
ity of correctly measuring samples contaminated at low (<30 ng l-1) and high levels (> 70 ng
l-1) and by using calibration curves carried out with freshly prepared strips; nevertheless, it
could not be confirmed for periods longer than a month.
4. Conclusions
Despite LFIAs still being regarded in some ways as an emerging and incoming technology for
food safety monitoring, there are several examples of fully developed devices described in the
literature and also available as commercial kits for detecting a variety of natural and xenobi‐
otic contaminants. Annual updates of state-of-the-art techniques underline the growing inter‐
est in the field and the increasing relevance of this technology over more established screening
techniques. Not with standing the research is conditioned by the attainment of effectively
functioning devices, often at the expense of true innovation, except in a few rare cases.
The literature concerning lateral flow immunoassays for aflatoxins is stilllimited, partly be‐
cause the subject is very recent; indeed, the first published work on this topic dates back to
just adecade ago. From this pioneering approach, several papers have been published which
describes devices mainly aimed at measuring aflatoxin B1. The use of LFDs for aflatoxin de‐
termination in nuts has also been demonstrated, even if the principal application is repre‐
sented by their use to monitor aflatoxin contamination in cereals and derived products. This
can be explained by the fact that research in this field is strongly driven by industry and by
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the prevalent economic impact of cereals in comparison to other commodities potentially af‐
fected by aflatoxin contamination.
The development of reliable devices for AFM1 detection, conversely, suffers the extreme sen‐
sitivity required to analytical methods aimed at measuring such a contaminant. Very few
papers have been published which describe LFIAs for AFM1and none actually meet those
requirements, despite the high interest in obtaining adequate systems for the rapid and on
site monitoring of this toxin.
In this paper, we demonstrated that modifying the format of the classic lateral flow assay
(such as tailoring the toxin conjugate, used as the competitor in the T-line, and the anti‐
body labelling procedure)a greatdetect ability improvement could be obtained. The estimat‐
ed LOD of the developed semi-quantitative LFIA was one order of magnitude lower than
previously published LFIAs for AFM1, therefore allowed us to effectively discriminate be‐
tween compliant and noncompliant samples at a level required by the most severe legisla‐
tion in force. Matrix-matched calibration was necessary to level results obtained on milk
samples,  however,  various matrices (undergone to different  thermal  treatment and with
differing fat contents) could be analysed after a very rapid and easy sample treatment, which
involves 2’  centrifugation followed by the addition of a small  volume of a concentrated
solution of a surfactant.
Author details
Laura Anfossi*, Claudio Baggiani, Cristina Giovannoli and Gianfranco Giraudi
*Address all correspondence to: laura.anfossi@unito.it
Department of Chemistry, University of Turin, Giraudi
References
[1] International Agency for Research on Cancer (IARC). (2002). Evaluation of carcino‐
genic risks in humans. 82, Lyon (France):IARC, 171-274.
[2] European Commission. (2006). Commission Regulation (EC) No 1881/2006 of 19 De‐
cember 2006 setting maximum levels for certain contaminants in foodstuffs. Official
Journal of the European Community, L364, 5-24.
[3] European Commission. (2010). Commission Regulation (EU) No 165/2010 of 26 Feb‐
ruary 2010 amending Regulation (EC) No 1881/2006 setting maximum levels for cer‐
tain contaminants in foodstuffs as regards aflatoxins. Official Journal of the European
Community, L050, 8-12.
[4] European Commission. (2003). Commission Directive 2003/100/EC of 31 October
2003 amending Annex I to Directive 2002/32/EC of the European Parliament and of
Lateral Flow Immunoassays for Aflatoxins B and G and for Aflatoxin M1
http://dx.doi.org/10.5772/51777
333
the Council on undesirable substances in animal feed. Official Journal of the European
Community, L285, 33-37.
[5] U.S. Food and Drug Administration. (2012). FDA Regulatory Guidance for Toxin‐
sand Contaminants. http://www.ngfa.org/files/misc/Guidance_for_Toxins.pdf, ac‐
cessed June.
[6] Canadian Food Inspection Agency. (2012). Fact sheet- Mycotoxins. http://
www.inspection.gc.ca/english/anima/feebet/pol/mycoe.shtml, accessed 12 June.
[7] European Mycotoxins Awareness Network. (2012). Mycotoxins Legislation World‐
wide. (last updated February)., http://services.leatherheadfood.com/eman/Fact‐
Sheet.aspx?ID=79, accessed 25 June 2012.
[8] U.S. Food and Drug Administration. (2012). Guidance for Industry: Action Levels for
Poisonous or Deleterious Substances in Human Food and Animal Feed. http://
www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocu‐
ments/ChemicalContaminantsandPesticides/ucm077969.htm, accessed 13 June.
[9] Shephard, G. S. (2009). Aflatoxin analysis at the beginning of the twenty-first centu‐
ry. Analytical and Bioanalytical Chemistry, 395-1215.
[10] Köppen, R., Koch, M., Siegel, D., Merkel, S., Maul, R., et al. (2010). Determination of
mycotoxins in foods: current state of analytical methods and limitations. Applied Mi‐
crobiology and Biotechnology, 86-1595.
[11] Sforza, S., Dall’Asta, C., & Marchelli, R. (2006). Recent advances in mycotoxin deter‐
mination in food and feed by hyphenated chromatographic techniques/mass spec‐
trometry. Mass Spectrometry Review, 25-54.
[12] Muscarella, M., Lo, Magro. S., Palermo, C., & Centonze, D. (2007). Validation accord‐
ing to European Commission Decision 2002/657/EC of a confirmatory method for
aflatoxin M1 in milk based on immunoaffinity columns and high performance liquid
chromatography with fluorescence detection. Analitica Chimica Acta, 594(2), 257-264.
[13] Chen, W.L, Hsu, T.F, & Chen, C.Y. (2011). Measurement of aflatoxin M1 in milk by
ultra-high-performance liquid chromatography/tandem mass spectrometry. Journal
of AOAC International, 94(3), 872-877.
[14] Betina, V. (1985). Thin-layer chromatography of mycotoxins. Journal of Chromatogra‐
phy, 334(3), 211-76.
[15] Reiter, E., Zentek, J., & Razzazi, E. (2009). Review on sample preparation strategies
and methods used for the analysis of aflatoxins in food and feed. Molecular Nutrition
and Food Research, 53(4), 508-524.
[16] Li, P., Zhang, Q., & Zhang, W. (2009). Immunoassays for aflatoxins. Trends in Analyti‐
cal Chemistry;, 28(9), 1115-1126.
[17] Trombley, A., Fan, T., & La Budde, R. (2011). Aflatoxin plate kit Performance Tested
Method 081003. Journal of AOAC International, 94(5), 1519-1530.
Aflatoxins - Recent Advances and Future Prospects334
[18] Lupo, A., Roebuck, C., Dutcher, M., Kennedy, J., & Abouzied, M. (2010). Validation
study of a rapid ELISA for detection of aflatoxin in corn Performance Tested Method
050901. Journal of AOAC International, 93(2), 587-599.
[19] Magliulo, M., Mirasoli, M., Simoni, P., Lelli, R., Portanti, O., & Roda, A. (2005). De‐
velopment and validation of an ultrasensitive chemiluminescent enzyme immunoas‐
say for aflatoxin M1 in milk. Journal of Agricultural and Food Chemistry, 53(9),
3300-3305.
[20] Anfossi, L, Calderara, M, Baggiani, C, Giovannoli, C, Arletti, E, & Giraudi, G. (2008).
Development and application of solvent-free extraction for the detection of aflatoxin
M1 in dairy products by enzyme immunoassay. Journal of Agricultural and Food Chem‐
istry, 56(6), 1852-1857.
[21] Guan, D., Li, P., Cui, Y., Zhang, Q., & Zhang, W. (2011). A competitive immunoassay
with a surrogate calibrator curve for aflatoxin M1 in milk. Analytica Chimica Acta;,
703(1), 64-9.
[22] Zheng, M. Z., Richard, J. L., & Binder, J. (2006). A review of rapid methods for the
analysis of mycotoxins. Mycopathologia, 161-261.
[23] Sibanda, L., De Saeger, S., & Van Peteghem, C. (1999). Development of a portable
field immunoassay for the detection of aflatoxin M1 in milk. International Journal of
Food Microbiology, 48(3), 203-209.
[24] Goryacheva, I. Y., Karagusheva, M. A., Van Peteghem, C., Sibanda, L., & De Saeger,
S. (2009). Immunoaffinity pre-concentration combined with on-column visual detec‐
tion as a tool for rapid aflatoxin M1 screening in milk. Food Control, 20(9), 802-806.
[25] Goryacheva, I. Y., De Saeger, S., Nesterenko, I. S., Eremin, S. A., & Van Peteghem, C.
(2007). Rapid all-in-one three-step immunoassay for non-instrumental detection of
ochratoxin A in high-coloured herbs and spices. Talanta, 72(3), 1230-1234.
[26] Ediage, E. N., Di Mavungu, J. D., Goryacheva, I. Y., Van Peteghem, C., & De Saeger,
S. (2012). Multiplex flow-through immunoassay formats for screening of mycotoxins
in a variety of food matrices. Analytical and Bioanalytical Chemistry, 403-265.
[27] Ricci, F., Volpe, G., Micheli, L., & Palleschi, G. (2007). A review on novel develop‐
ments and applications of immunosensors in food analysis. Analytica Chimica Acta,
605-111.
[28] Tang, D., Zhong, Z., Niessner, R., & Knopp, D. (2009). Multifunctional magnetic
bead-based electrochemical immunoassay for the detection of aflatoxin B1 in food.
Analyst, 134(8), 1554-60.
[29] Zaijun, L., Zhongyun, W., Xiulan, S., Yinjun, F., & Peipei, C. (2010). A sensitive and
highly stable electrochemical impedance immunosensor based on the formation of
silica gel-ionic liquid biocompatible film on the glassy carbon electrode for the deter‐
mination of aflatoxin B1 in bee pollen. Talanta, 80(5), 1632-1637.
Lateral Flow Immunoassays for Aflatoxins B and G and for Aflatoxin M1
http://dx.doi.org/10.5772/51777
335
[30] Tan, Y., Chu, X., Shen, G. L., & Yu, R. Q. (2009). A signal-amplified electrochemical
immunosensor for aflatoxin B1 determination in rice. Analytical Biochemistry;, 387(1),
82-86.
[31] Pohanka, M, Malir, F, Roubal, T, & Kuca, K. (2008). Detection of Aflatoxins in Capsi‐
cum Spice Using an Electrochemical Immunosensor. Analytical Letters, 41(13),
2344-2353.
[32] Jin, X., Jin, X., Chen, L., Jiang, J., Shen, G., & Yu, R. (2009). Piezoelectric immunosen‐
sor with gold nanoparticles enhanced competitive immunoreaction technique for
quantification of aflatoxin B1. Biosensensors and Bioelectronics, 24(8), 2580-2585.
[33] Micheli, L., Grecco, R., Badea, M., Moscone, D., & Palleschi, G. (2005). An electro‐
chemical immunosensor for aflatoxin M1 determination in milk using screen-printed
electrodes. Biosensensors and Bioelectronics, 21(4), 588-596.
[34] Parker, C. O., Lanyon, Y. H., Manning, M., Arrigan, D. W., & Tothill, I. E. (2009).
Electrochemical immunochip sensor for aflatoxin M1 detection. Analytical Chemistry,
81(13), 5291-5298.
[35] Kanungo, L., Pal, S., & Bhand, S. (2011). Miniaturised hybrid immunoassay for high
sensitivity analysis of aflatoxin M1 in milk. Biosensensors and Bioelectronics, 26(5),
2601-2606.
[36] Piletska, E., Karim, K., Coker, R., & Piletsky, S. (2010). Development of the custom
polymeric materials specific for aflatoxin B1 and ochratoxin A for application with
the ToxiQuant T1 sensor tool. Journal of Chromatography A, 1217(16), 2543-2547.
[37] Baggiani, C., Anfossi, L., & Giovannoli, C. (2008). Molecular imprinted polymers as
synthetic receptors for the analysis of myco- and phyco-toxins. Analyst, 133(6),
719-730.
[38] Molina-García, L., Fernández-de Córdova, M. L., & Ruiz-Medina, A. (2012). Indirect
determination of aflatoxin B1 in beer via a multi-commuted optical sensor Food Ad‐
ditives & Contaminants. Part A: Chemistry, Analysis, Control, Exposure & Risk Assess‐
ment, 29(3), 392-402.
[39] Wang, Y., Dostálek, J., & Knoll, W. (2009). Long range surface plasmon-enhanced flu‐
orescence spectroscopy for the detection of aflatoxin M1 in milk. Biosensensors and Bi‐
oelectronics, 24(7), 2264-7.
[40] Arduini, F., Errico, I., Amine, A., Micheli, L., Palleschi, G., & Moscone, D. (2007). En‐
zymatic Spectrophotometric Method for Aflatoxin B Detection Based on Acetylcholi‐
nesterase Inhibition. Analytical Chemistry, 79-3409.
[41] Posthuma-Trumpie, G. A., Korf, J., & Van Amerongen, A. (2009). Lateral flow (im‐
muno)assay: its strengths, weakness, opportunities and threats. A literature survey.
Analytical and Bioanalytical Chemistry, 393-569.
Aflatoxins - Recent Advances and Future Prospects336
[42] Krska, R., & Molinelli, A. (2009). Rapid test strips for analysis of mycotoxins in food
and feed. Analytical and Bioanalytical Chemitry, 393-67.
[43] Ngom, B., Guo, Y., Wang, X., & Bi, D. (2010). Development and application of lateral
flow test strip technology for detection of infectious agents and chemical contami‐
nants: a review. Analytical and Bioanalytical Chemitry, 397-1113.
[44] Anfossi, L., Baggiani, C., Giovannoli, C., D’Arco, G., & Giraudi, G. (2012). Lateral-
flow immunoassays for mycotoxins and phycotoxins: a review. Analytical and Bioana‐
lytical Chemistry, 1-14, DOI s00216-012-6033-4.
[45] U.S. Department of Agriculture. (2012). GIPSA Performance Verified Rapid Test Kits
for Analysis of Mycotoxins. http://www.gipsa.usda.gov/fgis/tech-servsup/metheqp/
testkits.pdf, accessed June.
[46] Anfossi, L., Calderara, M., Baggiani, C., Giovanoli, C., Arletti, E., & Giraudi, G.
(2010). Development and application of a quantitative lateral flow immunoassay for
fumonisins in maize. Analytica Chimica Acta;, 682-104.
[47] Laycock, M. V, Donovan, M. A, & Easy, D. J. (2010). Sensitivity of lateral flow tests to
mixtures of saxitoxins and applications to shellfish and phytoplankton monitoring.
Toxicon, 55-597.
[48] Komano, A., Maruko, H., Sekiguchi, H., & Seto, Y. (2011). Detection of saxitoxin in
counterterrorism using a commercial lateral flow immunoassay kit. Forensic Toxicolo‐
gy, 2938-43.
[49] Ho, J. A, & Wauchope, R. D. (2002). A Strip Liposome Immunoassay for Aflatoxin B1.
Analytical Chemistry;, 74-1493.
[50] Delmulle, B. S., De Saeger, S. M., Sibanda, L., Barna-Vetro, I., & Van Peteghem, C. H.
(2005). Development of an Immunoassay-Based Lateral Flow Dipstick for the Rapid
Detection of Aflatoxin B1 in Pig Feed. Journal of Agricultural and Food Chemistry,
53-3364.
[51] Xiulan, S., Xiaolian, Z., Jiana, T., Zhoub, J., & Chu, F. S. (2005). Preparation of gold-
labeled antibody probe and its use in immunochromatography assay for detection of
aflatoxin B1. International Journal of Food Microbiology, 99-185.
[52] Xiulan, S., Xiaolian, Z., Jian, T., Xiaohong, G., Jun, Z., & Chu, F. S. (2006). Develop‐
ment of an immunochromatographic assay for detection of aflatoxin B1 in foods. Food
Control, 17-256.
[53] Shim, W. B, Yang, Z. Y, Kim, J. S, Kim, J. Y, Kang, S. J, Woo, G. J, Chung, Y. C, Ere‐
min, S. A, & Chung, D. H. (2007). Development of immunochromatography strip-test
using nanocolloidal gold-antibody probe for the rapid detection of aflatoxin B1 in
grain and feed samples. Journal of Microbiology and Biotechnology, 171629-1637.
[54] Shim, W. B, Kim, J. S, Kim, J. Y, Choi, J. G, Je, J. H, Kuzmina, N. S, Eremin, S. A, &
Chung, D. H. (2008). Determination of aflatoxin B1 in rice, barley, and feed by non-
Lateral Flow Immunoassays for Aflatoxins B and G and for Aflatoxin M1
http://dx.doi.org/10.5772/51777
337
instrumental immunochromatographic strip-test and high sensitive ELISA. Food Sci‐
ence and Biotechnology;, 17623-630.
[55] Shim, W. B., Kim, G., Ryu, H. J., Nam, M., & Chung, D. H. (2009). Development of
One-step Simultaneous Immunochromatographic Assay for Rapid Analysis of Afla‐
toxin B1 and Ochratoxin A. Food Science and Biotechnology, 18(3), 641-648.
[56] Anfossi, L., D’Arco, G., Calderara, M., Baggiani, C., Giovannoli, C., & Giraudi, G.
(2011). Development of a quantitative lateral flow immunoassay for the detection of
aflatoxins in maize. Food Additives & Contaminants: Part A: Chemistry, Analysis, Con‐
trol, Exposure & Risk Assessment, 28(2), 226-234.
[57] Zhang, D., Li, P., Yang, Y., Zhang, Q., Zhang, W., Xiao, Z., & Ding, X. (2011). A high
selective immunochromatographic assay for rapid detection of aflatoxin B1. Talanta,
85-736.
[58] Zhang, D., Li, P., Zhang, Q., & Zhang, W. (2011). Ultrasensitive nanogold probe-
based immunochromato graphic assay for simultaneous detection of total aflatoxins
in peanuts. Biosensors and Bioelectronics, 26-2877.
[59] Liao, J. Y., & Li, H. (2010). Lateral flow immunodipstick for visual detection of afla‐
toxin B1 in food using immuno-nanoparticles composed of a silver core and a gold
shell. Microchimica Acta, 171(3-4), 289-295.
[60] Tang, D., Sauceda, J. C., Lin, Z., Ott, S., Basova, E., Goryacheva, I., Biselli, S., Lin, J.,
Niessner, R., & Knopp, D. (2009). Magnetic nanogold microspheres-based lateral-
flow immunodipstick for rapid detection of aflatoxin B2 in food. Biosensors and Bioe‐
lectronics, 25-514.
[61] Anfossi, L, D’Arco, G, Baggiani, C, Giovannoli, C, & Giraudi, G. (2011). A lateral flow
immunoassay for measuring ochratoxin a: development of a single system for maize,
wheat and durum wheat. Food Control, 22(12), 1965-1970.
[62] Molinelli, A., Grossalber, K., Führer, M., Baumgartner, S., Sulyok, M., & Krska, R.
(2008). Development of Qualitative and Semiquantitative Immunoassay-Based Rapid
Strip Tests for the Detection of T-2 Toxin in Wheat and Oat. Journal of Agricultural and
Food Chemistry, 56-2589.
[63] Molinelli, A., Grossalber, K., & Krska, R. (2009). A rapid lateral flow test for the de‐
termination of total type B fumonisins in maize. Analytical and Bioanalytical Chemistry,
395-1309.
[64] Salter, R., Douglas, D., Tess, M., Markovsky, B., & Saul, S. J. (2006). Interlaboratory
study of the Charm ROSA Safe Level Aflatoxin M1 Quantitative lateral flow test for
raw bovine milk. Journal of AOAC International, 89(5), 1327-34.
[65] Wang, J. J, Liu, B. H, Hsu, Y. T, & Yu, F. Y. (2011). Sensitive competitive direct en‐
zyme-linked immunosorbent assay and gold nanoparticle immunochromatographic
strip for detecting aflatoxin M1 in milk. Food Control, 22-964.
Aflatoxins - Recent Advances and Future Prospects
[66] Zhang, D., Li, P., Zhang, Q., Yang, Y., Zhang, W., Guan, D., & Ding, X. (2012). Ex‐
tract-free immunochromatographic assay for on-site tests of aflatoxin M1 in milk An‐
alytical Methods. Accepted Manuscript, DOI:10.1039/C2AY25205H.
[67] Liu, Y. H., Xie, R., Guo, Y. R., Zhu, G. N., & Tang, F. B. (2012). Comparison of homol‐
ogous and heterologous formats in nanocolloidal gold-based immunoassays for par‐
athion residue determination. Journal of Environmental and Science and Health Part. B,
Pesticides, Food contaminants and agricultural wastes, 47(5), 475-83.
[68] Byzova, N. A, Zvereva, E. A, Zherdev, A. V, Eremin, S. A, Sveshnikov, P. G, & Dzan‐
tiev, B. B. (2011). Pretreatment-free immunochromatographic assay for the detection
of streptomycin and its application to the control of milk and dairy products. Analyti‐
ca Chimica Acta;, 701(2), 209-217.
[69] Horsiberger, M., & Rosset, J. (1977). Colloidal gold, a useful marker for transmission
and scanning electron microscopy. Journal of Histochemistry and Cytochemistry, 25-295.
[70] Findlay, J. W., Smith, W. C., Lee, J. W., Nordblom, G. D., Das, I., De Silva, B. S., Khan,
M. N., & Bowsher, R. R. (2000). Validation of immunoassays for bioanalysis: a phar‐
maceutical industry perspective. Journal of Pharmaceutical and Biomedical Analysis,
21-1249.
[71] European Commission. (2006). Commission Regulation (EC) No 401/2006 of 23 Feb‐
ruary 2006 laying down the methods of sampling and analysis for the official control
of the levels of mycotoxins in foodstuffs. Official Journal of the European Community,
L070, 12-34.
Lateral Flow Immunoassays for Aflatoxins B and G and for Aflatoxin M1
http://dx.doi.org/10.5772/51777
339

